能谱CT在神经内分泌肿瘤临床常规成像中的应用
前瞻性纳入88例神经内分泌肿瘤患者,行多期能谱与标准模式CT,评估虚拟单能量图像信噪比/对比噪声比、碘浓度及衰减斜率。低能级虚拟单能量图像中肿瘤-肝脏信噪比/对比噪声比显著提高,原发灶与转移灶碘浓度及衰减斜率差异显著(p<0.001),能谱与标准模式辐射剂量相当,但能谱参数与肿瘤分级无显著相关,无法预测6个月随访的肿瘤反应。
要点
- 低能级虚拟单能量图像可显著提高神经内分泌肿瘤的肿瘤-肝脏信噪比和对比噪声比。
- 原发灶与转移灶的碘浓度(总量及热点)和衰减斜率差异显著(p<0.001)。
- 能谱CT参数与肿瘤分级无显著相关,且不能预测6个月随访的肿瘤反应。
核心结论
- 能谱CT在辐射剂量方面与标准模式相当,可改善肿瘤对比度,并有助于区分原发神经内分泌肿瘤与转移灶。
研究设计与样本
- 前瞻性纳入88例连续神经内分泌肿瘤患者,行多期能谱与标准模式CT,比较肿瘤-肝脏信噪比/对比噪声比、碘浓度(肿瘤总量/热点)及虚拟单能量图像衰减斜率,并分析能谱参数与原发肿瘤位置、分级、原发灶与转移灶鉴别及6个月随访肿瘤反应预测的关系。
关键影像表现/征象
- 低能级虚拟单能量图像中肿瘤-肝脏信噪比/对比噪声比显著升高。
- 原发灶与转移灶的碘浓度(绝对值和标准化值,无论测量肿瘤总量还是热点)差异显著(p<0.001)。
- 原发灶与转移灶的衰减斜率差异显著(p<0.001)。
诊断标准与关键数值
- 原发灶与转移灶碘浓度差异显著(p<0.001),绝对值和标准化值、肿瘤总量和热点测量均一致。
- 原发灶与转移灶衰减斜率差异显著(p<0.001)。
- 能谱CT参数与肿瘤分级无显著相关。
- 能谱CT参数无法预测6个月随访的肿瘤反应。
- 能谱模式与标准模式辐射剂量相当。
临床应用与阅片要点
- 日常阅片可利用低能级虚拟单能量图像提高神经内分泌肿瘤与肝脏的对比度。
- 碘浓度和衰减斜率可用于辅助区分原发灶与转移灶。
- 能谱参数不宜用于推断肿瘤分级或预测6个月随访的肿瘤反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the potential of new spectral computed tomography (SCT)-based tools in patients with neuroendocrine neoplasms (NEN).
MATERIAL AND METHODS: Eighty-eight consecutive patients with NENs were included prospectively. The patients underwent multiphase CT with spectral and standard mode. The signal-to-noise ratio (SNR)/contrast-to-noise-ratio (CNR)tumour-to-liver, iodine concentrations (ICs, total tumour/hotspot) and attenuation slopes in virtual monochromatic images (VMIs) were used to assess NEN-specific SCT values in primary tumours and metastatic lesions and investigate a possible lesion contrast improvement as well as possible correlations of SCT parameters to primary tumour location and tumour grade. Furthermore, the usability of SCT parameters to differentiate between the primary tumour and metastatic lesions, and to predict tumour response after 6-months follow-up was analyzed. The applied dose of spectral and standard mode was compared intra-individually.
RESULTS: SNR/CNRtumour-to-liver significantly increased in low-energy VMIs. NENs showed significant differences in ICs between primary and metastatic lesions for both absolute and normalised values (p<0.001) regardless of whether the total tumour or the hotspot was measured. There was also a significant difference in the attenuation slope (p<0.001). No significant correlations were found between SCT and tumour grade. A tumour response prediction by SCT parameters was not possible. The applied dose was comparable between the scan modes.
CONCLUSION: SCT was comparable regarding applied dose, improved tumour contrast, and contributed to differentiation between primary NEN and metastasis.
引用
- Böning G, Adelt S, Feldhaus F, et al. Spectral CT in clinical routine imaging of neuroendocrine neoplasms. Clin Radiol. 2021. PMID: 33610290. doi:10.1016/j.crad.2020.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。